G-I Holdings Asbestos Settlement Trust Claims
The formal trust is the G-I Holdings Inc. Asbestos Personal Injury Settlement Trust. It was created in 2009 through confirmation of the G-I Holdings Inc. and ACI Inc. Chapter 11 reorganization plan to process and pay valid asbestos personal-injury claims involving liabilities for which G-I and its predecessors, successors or assigns bear legal responsibility. G-I is associated with historic GAF/Ruberoid asbestos-containing products. The Trust remains active and is administered by Verus Claims Services, LLC.
G-I Holdings Asbestos Trust Facts
| Official trust name | G-I Holdings Inc. Asbestos Personal Injury Settlement Trust |
|---|---|
| Associated debtors | G-I Holdings Inc. and ACI Inc. |
| Trust creation | 2009 |
| Claims accepted beginning | October 4, 2010 |
| Initial Claim Filing Date | April 4, 2011 |
| Claims administrator | Verus Claims Services, LLC |
| Current payment handling | Claims first eligible for payment after November 22, 2022 are paid at 5% under the Trust’s December 1, 2022 official notice until the proposed decrease is resolved |
| Prior Payment Percentage | 7.4%; Trust temporarily resumed payments at 6% before the later 5% interim handling described in the December 2022 notice |
| Mesothelioma base TDP value | $155,000 Scheduled / $225,000 Average / $450,000 Maximum |
| Current status | Active |
Bankruptcy and Trust History
The official Trust website states that the G-I Holdings Inc. Asbestos Personal Injury Settlement Trust was created in 2009 as a result of confirmation of the G-I Holdings Inc. Chapter 11 Joint Plan of Reorganization.
Federal confirmation records identify the trust as a Section 524(g) asbestos trust established to resolve present and future asbestos personal-injury claims against G-I Holdings Inc., ACI Inc. and covered parties under the Plan.
The Trust began accepting claims on October 4, 2010, and established April 4, 2011 as the Initial Claim Filing Date.
Who May Qualify for a G-I Claim?
The TDP recognizes eight Disease Levels: Mesothelioma, Lung Cancer 1, Lung Cancer 2, Other Cancer, Severe Asbestosis, two Asbestosis/Pleural Disease levels and Other Asbestos Disease.
Eligibility depends on a qualifying asbestos-related diagnosis and proof of G-I Exposure to products or conduct for which G-I has legal responsibility. The Trust separately publishes a GAF/Ruberoid asbestos-containing product list and approved site materials to assist with exposure review.
The TDP also contains procedures for Extraordinary Claims, Exigent Hardship Claims, Secondary Exposure Claims, Indirect Claims, Foreign Claims, arbitration and litigation.
Disease Levels and Claim Values
The Second Amended TDP publishes the following base Scheduled, Average and Maximum Values:
| Disease Level | Scheduled Value | Average Value | Maximum Value |
|---|---|---|---|
| Mesothelioma — Level VIII | $155,000 | $225,000 | $450,000 |
| Lung Cancer 1 — Level VII | $45,000 | $55,000 | $100,000 |
| Lung Cancer 2 — Level VI | None | $15,000 | $35,000 |
| Other Cancer — Level V | $15,000 | $18,000 | $35,000 |
| Severe Asbestosis — Level IV | $30,000 | $35,000 | $50,000 |
| Asbestosis/Pleural Disease — Level III | $8,300 | None | None |
| Asbestosis/Pleural Disease — Level II | $2,625 | None | None |
| Other Asbestos Disease — Level I | $150 Cash Discount Payment in the base TDP | None | None |
The TDP requires periodic inflation adjustments. An official 2015 notice confirms that the Trust has in fact adjusted these values for inflation. Because no current 2026 inflation-adjusted value table was located in the official materials reviewed, this page labels the figures above as the base TDP values rather than presenting them as current 2026 adjusted values.
Need help now? Call 800.291.0963
Live chat available 24/7, 365 days a year.
Submit Your Case
Current Payment-Percentage Handling
The Trust’s official December 1, 2022 notice explains a multi-step change in payment handling. The Trustees first sought to reduce the Payment Percentage from 7.4% to 6% and temporarily directed Verus to resume claim payments at 6%.
The same notice states that on November 22, 2022 the Trustees sought consent either to maintain 6% with an inflation cap or decrease the Payment Percentage to 5%. It then expressly directs that claims first eligible for payment after November 22, 2022 will be paid at 5% until the proposed decrease is resolved.
No later official G-I notice resolving that proposal or replacing the 5% interim payment handling was located in the current Trust resource library reviewed for this page. Accordingly, this page does not overstate 5% as a permanently adopted percentage; it accurately describes the Trust’s published current payment handling.
Mathematical illustration only — not a guaranteed payment. Using the base TDP Mesothelioma Scheduled Value of $155,000 × 5% equals $7,750. Because current liquidated values may include inflation adjustments and payment rules may change, this is not a current claim quote or guaranteed payment.
Expedited and Individual Review
Expedited Review is available for Disease Levels I–V, VII and VIII when the claim meets the presumptive medical and exposure criteria. A qualifying ER claim is liquidated at the applicable Scheduled Value, subject to any current inflation adjustment and the applicable Payment Percentage.
Individual Review is available for claims that do not meet all presumptive ER criteria and for claimants seeking individualized valuation of Disease Levels IV, V, VII and VIII. Lung Cancer 2 and Foreign Claims are handled through Individual Review.
The TDP states that Individual Review may produce a value below the Scheduled Value and generally cannot exceed the published Maximum Value unless the claim qualifies as Extraordinary.
Medical and Exposure Requirements
Mesothelioma Level VIII requires a qualifying diagnosis of mesothelioma and G-I Exposure. Lung Cancer 1 requires primary lung cancer, evidence of underlying bilateral asbestos-related nonmalignant disease, at least six months of G-I Exposure before December 31, 1982, Significant Occupational Exposure and medical support establishing asbestos exposure as a contributing factor.
Other Cancer, Severe Asbestosis and several nonmalignant levels also impose disease-specific medical proof and exposure requirements. The Trust’s filing instructions state that claimant-signed forms under penalty of perjury can be accepted as exposure evidence for specified purposes when fully completed.
The TDP’s medical-evidence provisions require malignancy diagnoses to be supported by appropriate physician examination or qualifying pathology evidence. Pulmonary-function and radiographic evidence may be required for nonmalignant disease levels.
Current Filing and Administration Status
The Trust remains active. Its official Resources page currently provides the TDP, payment-percentage notices, claim forms, filing instructions, GAF/Ruberoid product information, approved site lists, secondary-exposure rules, ACH forms and other claim materials.
The official contact page identifies Verus Claims Services, LLC as the claims administrator.
An official policy effective April 1, 2025 establishes a 180-day cure period for identified deficient claims and provides that an uncured or undeferred deficient claim may be deemed withdrawn under the TDP.
A sufficiently current audited financial report establishing 2025 or 2026 total assets, cumulative claims paid and lifetime dollars paid was not located in the Trust’s public primary-source materials reviewed for this page. Those figures are therefore omitted.
Confirmed Primary Sources for Trust Facts
No law-firm or lead-generation website was used as factual authority for this page. Primary Trust and government materials reviewed include:
- Official G-I Holdings Inc. Asbestos Personal Injury Settlement Trust website.
- Official Trust Resources page.
- Official Second Amended Trust Distribution Procedures.
- Official December 1, 2022 Payment Percentage notice.
- Official notice confirming inflation-adjusted claim values.
- Official filing instructions.
- Official Verus claims-administration contact information.
- Federal G-I Holdings plan confirmation record.
Related Asbestos Trust Fund Resources
Asbestos Trust Fund Information
Filing and Eligibility
Payments and Trust Rules
Frequently Asked Questions About the G-I Holdings Asbestos Trust
What is the official G-I asbestos trust name?
It is the G-I Holdings Inc. Asbestos Personal Injury Settlement Trust.
Is the G-I Holdings Trust active?
Yes. The Trust maintains current claim materials and continues to be administered by Verus Claims Services, LLC.
What payment percentage is G-I currently using?
The Trust’s December 1, 2022 notice states that claims first eligible for payment after November 22, 2022 will be paid at 5% until the Trustees’ proposed decrease is resolved. No later official resolution replacing that instruction was located in the current resource library reviewed.
What is the G-I mesothelioma Scheduled Value?
The base TDP lists $155,000 Scheduled, $225,000 Average and $450,000 Maximum for Mesothelioma Level VIII. The TDP also requires periodic inflation adjustments.
What would 5% of the base mesothelioma Scheduled Value equal?
$155,000 multiplied by 5% equals $7,750. This is a mathematical illustration only, not a guaranteed payment or current claim offer.
Does G-I offer Individual Review?
Yes. The Trust provides both Expedited Review and Individual Review, while Lung Cancer 2 and Foreign Claims are processed through Individual Review.
What exposure cutoff applies to several G-I Disease Levels?
Several Disease Levels require at least six months of qualifying G-I Exposure before December 31, 1982, together with other occupational and medical requirements.
Who administers G-I Holdings asbestos claims?
The official contact page identifies Verus Claims Services, LLC as the claims administrator.
Get Help Reviewing a G-I Holdings Asbestos Claim
Call 800.291.0963
Live chat is available 24/7, 365 days a year.
Prior exposure to a GAF, Ruberoid or other product associated with G-I does not automatically establish eligibility for a G-I Holdings Trust claim. Eligibility depends on medical evidence, exposure evidence, current Trust procedures, applicable filing requirements and individual circumstances. Compensation is not guaranteed.
⚕️ Legal & Medical Information Disclaimer
This page provides general educational information and is not medical or legal advice. The information does not establish asbestos exposure, diagnosis, causation, liability, claim eligibility or compensation. Medical concerns should be discussed with a qualified healthcare professional, and legal questions should be reviewed with a qualified attorney.